-
In the Moment- Summer 2018
Jessica Melore, NJ DeVico, Steve Nolan, Rosemarie Rogers.
-
Advocacy Spotlight: Sorting Out Priorities
Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
In the Moment- Spring 2018
Kwesi Rollins, Jonathan Passley, Cameron Moon
-
Gaps in End-of-Life Care
Racial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.
by Charlotte Huff
-
Survivor Profile
Family MattersAfter Shigeo Tsuruoka was diagnosed with stomach cancer, his family came together to help him. His daughter, Aki Smith, was by his side as he navigated treatment and recovery. Now she offers guidance to other stomach cancer patients and caregivers.
by Kate Yandell
-
Targeting Brain Cancer
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
-
The Cost of Treatment
As efforts to change or repeal the Affordable Care Act continue, health care bills keep piling up for many cancer patients and caregivers.
by Sue Rochman
-
In the Moment- Winter 2017/2018
Lauren Chiarello Mika, Sandy Russell, Christopher Rios.
-
A Call to Care
Caregivers for cancer patients find themselves playing a complex and vital role as care shifts from the hospital to the home.
by Kate Yandell
-
Vaccines: Looking Within for Cancer Treatment
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin